434 In silico ADMET optimization and preliminary biologic activity of novel spermine oxidase inhibitors as neuroprotective agents
OBJECTIVES/GOALS: The goal of this project was to conduct a preliminary assessment of in vivo feasibility early on in the drug-discovery process in an effort to expedite the translation of novel drug scaffolds to potential clinical candidates. The data gathered in this study will be used to direct a...
Main Authors: | Amelia B Furbish, Pieter Burger, Yuri K Peterson, Patrick M Woster |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-04-01
|
Series: | Journal of Clinical and Translational Science |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866122002527/type/journal_article |
Similar Items
-
Identification and Characterization of Novel Small-Molecule SMOX Inhibitors
by: Amelia B. Furbish, et al.
Published: (2022-08-01) -
Structure of human spermine oxidase in complex with a highly selective allosteric inhibitor
by: Elsie Diaz, et al.
Published: (2022-08-01) -
The Spermine Oxidase/Spermine Axis Coordinates ATG5‐Mediated Autophagy to Orchestrate Renal Senescence and Fibrosis
by: Dan Luo, et al.
Published: (2024-08-01) -
Expression of Spermine Oxidase Is Associated with Colorectal Carcinogenesis and Prognosis of Patients
by: Sooyoun Kim, et al.
Published: (2022-03-01) -
Novel NADPH Oxidase-2 Inhibitors as Potential Anti-Inflammatory and Neuroprotective Agents
by: Matea Juric, et al.
Published: (2023-08-01)